使用体外数据和PBPK建模来预测IL-6介导的P450细胞染色体活性调节的现状
Viktor Georgiev1, Isabelle Anderka2, Delia Bucher2
1Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Roche Products Ltd, Welwyn, UK.
Drug metabolism and pharmacokinetics
|January 7, 2026
概括
基于生理学的药理动力学 (PBPK) 建模和体外数据可以预测IL-6药物相互作用. 一个新的机械PBPK模型改善了IL-6的预测.
科学领域:
- 药理动力学和药物新陈代谢
- 计算机生物学和建模
- 免疫学和炎症 免疫学和炎症
背景情况:
- 介乐-6 (IL-6) 在炎症中起着关键作用,可以影响药物代谢.
- 了解IL-6对细胞染色体P450 (CYP) 酶活性的影响对于预测药物相互作用至关重要.
- 目前评估IL-6介导CYP抑制的方法存在局限性.
研究的目的:
- 审查使用体外数据和基于生理学的药理动力学 (PBPK) 建模来预测IL-6介导的药物相互作用.
- 评估目前对IL-6释放机制的理解以及用于抑制CYP的体外模型.
- 为突出IL-6与药物相互作用的机械PBPK建模的进展.
主要方法:
- 关于IL-6的现有文献的全面审查,体外测试和PBPK建模.
- 对评估IL-6诱导的CYP抑制体外模型的分析.
- 评估最近开发的机械PBPK模型,整合IL-6受体生物学.
主要成果:
- 审查了IL-6释放机制和体外CYP抑制模型.
- 在此背景下评估了PBPK建模的过去和当前应用.
- 一种新的机械PBPK模型表明,在不同人群中对IL-6介导的CYP抑制具有良好的预测性能.
结论:
- 机械PBPK建模,整合IL-6受体生物学,显示预测药物相互作用的希望.
- 预计这种方法将影响有关药物安全的监管决策.
- 需要进一步的研究来解决IL-6动力学和体外-体内活体翻译方面的差距.
关键词:
(510):是由于CYP3A4的作用.抑制 CYP 的抑制.药物相互作用 药物相互作用在IL-6的研究中,IL-6被认为是IL-6的基因.一个IL-6受体复合体.在体外 (in vitro) 的情况下.在 PBPK 建模中使用 PBPK 模型.更多相关视频
10:44Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
10.2K
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
14.6K
相关概念视频
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
269
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
269
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
208
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
208